SLC4A3 and hypertrophic cardiomyopathy: More recently, loss of AE3 was shown to dramatically increase the rate of decompensation in a transgenic mouse α-tropomyosin Glu180Gly (TM180) hypertrophic cardiomyopathy (HCM) model.